chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My ears are ringing much louder than previously, I'm having stabbing pains in my wrists, arms, fingers, My wrists hurt so bad I couldn't pull my comforter up in the night and the pain woke me. I have been diagnosed with RA, but haven't had symptoms.  I have to rest frequently, had to stop three times just to walk over a walkway. Have a headache most of the time. Heart is beating irregularly. Noticed symptoms the following morning after the vaccine.  I have been waiting for them to go away, but am afraid it's gone on beyond a few days. I didn't know I should seek medical attention. I'm just hoping and praying it will go away.
fatigue; myalgia; pain all over body; This case was reported by a pharmacist via call center representative and described the occurrence of fatigue in a 57-year-old female patient who received Herpes zoster (Shingrix) (batch number AD9A5, expiry date 9th May 2022) for prophylaxis.   On 28th September 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced fatigue, myalgia and general body pain. On an unknown date, the outcome of the fatigue, myalgia and general body pain were unknown.   It was unknown if the reporter considered the fatigue, myalgia and general body pain to be related to Shingrix.  Additional details were provided as follows: The patient was vaccinated with dose of Shingrix and experienced fatigue, myalgia, and pain all over her body. The event onset time was not known. If events resolved or not was unknown. The reporter consent to follow up.
Patient had a red swollen painful area appear on her arm underneath the injection site. On the 16th the redness started to subside and come that night she was able to sleep on that arm
dose of Tdap on 2020 and Boostrix on 2021; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 47-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number PN7KN, expiry date 29th January 2023) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included ADACEL (TDAP) (received on an unknown date in September 2020).   On 8th October 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 8th October 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter was patient's assistance. The patient received a dose of Boostrix one year apart from Tdap Adacel which led to shortening of vaccination schedule. The reporter did consent to follow-up.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On 01-SEP-2017, the patients were vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # M044720, expiration date: 07-MAY-2018, lot # N013863, expiration date: 31-OCT-2018) for prophylaxis. Administered vaccine experienced the temperature excursion of -14 Celsius degree to -10 Celsius degree (-14.2 Celsius degree) for 6 hours. There was no previous temperature excursion. Data logger was involved. No adverse effects reported. No product quality complaint (PQC) was involved. All telephone attempts on 10-OCT-2017 to obtain follow up information have been unsuccessful. Follow up information has been received from another reporter concerning a 4 year old patient. On 12-SEP-2017, the patient vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # N013863, expiration date: 31-OCT-2018) for prophylaxis. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA002186: US-009507513-1709USA002098.
4DEC91 mom report pt still crying; 315PM tc MD in hosp ER reports pt ok but was still irritable; 5DEC91 mom reports pt cried off & on; 8JAN92 pt fine;
7/8/02 Client developed headaches and rash, red raised bumps appeared on chest. No fever, temp 98.2. Taking Naproxen sodium tablets at 12 hours for headache with results. 7/10/02 Rash progressed to back, face, back of neck and lets. 7/07/02 Start of headache.
Patient had pain in immunization arm, then swelling. Patient said felt warm to touch. Patient sought medical treatment. Said had bacterial infection and was given antibiotic. Immunizer admits not prepping site with alcohol.
Cough; Not able to stand up/extremally fatigued; Fever of 101°F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), FATIGUE (Not able to stand up/extremally fatigued), PYREXIA (Fever of 101°F) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 530M20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced COUGH (Cough), FATIGUE (Not able to stand up/extremally fatigued), PYREXIA (Fever of 101°F) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, COUGH (Cough), FATIGUE (Not able to stand up/extremally fatigued), PYREXIA (Fever of 101°F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Body temperature: 101 (High) 101 degree F.         Concomitant medication was not reported. The patient had high blood pressure so is not able to take Advil or Aspirin.
Patient reported itchiness and tingling in throat and lower extremities as well as hoarseness of voice. Reports that when she had an anaphylaxis reaction to shellfish it started the same way and progressed to occluded airway. Vitals were within normal limits and 911 was called for transport Hospital ED. Symptoms reported around 11:05, EMS arrived around 11:30 and patient transported around 11:40.
fever high of 104.2 degrees F. body aches, muscle aches, fatigue, headache
Information has been received from a female nurse practitioner concerning a 9 or 10 year old female, who was vaccinated with Gardasil vaccine intramuscularly in the arm. After the initial dose the patient did not have a menstrual cycle for 2 months afterward. When the patient returned for her second dose she was menstruating but when the second dose was administered the patient's cycle immediately stopped. The patient sought medical attention and no other information was given. Additional information has been requested.
3/25/23  I started to not feel well that afternoon, I was tired. That evening, I felt awful and was so tired. On 3/26/23  I tested positive with an at home COVID test.  I had a cough and tired. I felt better by midday 3/28/23. I tested negative with an at home COVID test on 3/30/23.  I had a lingering cough for about two weeks and still have a cough.
High fever of 103.1+ within 12 hours of vaccine, extreme neck pain, swollen throat, pain, headache, fatigue, dilated right pupil (only right eye). Treatment has been rest and Asprin at the time if this writing - 18hrs after vaccine.
1435 vaccine given 1440 tingling in tongue, lump in throat - no swelling, no SOB, no rash - monitor as she was anxious prior      to receiving vaccine 1444 states sxs are getting worse, still no swelling or SOB noted 1445 States she now feels like tongue is swelling and lump in throat is worse, cough noted.  99.5F, 97% RA, 102HR, 22 Resp, 146/99 BP 1448 Hoarseness in voice noted as associate getting into wheelchair 1449 Turn over care to ED
I am having A-fib. I am having heart problems after my vaccine. Several tests were performed due to my symptoms, EKG's, stress tests and CT scans, and Ultrasound of the heart. I continue having A-fib.
Received Typhoid, TDAP, Anthrax, and FLUMIST as required for pending deployment received 18 Nov 10. Noticed itching and redness followed by swelling 19Nov10. Presented 22Nov10 for f/u with no change BENADRYL 50mg cap 1 po q 6 hours for 48hrs.
p/vax lt arm red, hot, swollen; head to toe rash on body; unable to walk; admit to hosp x2 days
Suspected Vaccination Failure; I had shingles shot. Have had shingles twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient himself/herself. The age at vaccination was not reported. The patient received the dose of Shingles vaccine and had shingles twice. The reporter stated that it would have been worse without the shot. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Information has been received from a nurse practitioner concerning an 18 year old female with no known allergies who was vaccinated with Gardasil.  There was no concomitant medication.  Subsequently the patient experienced arm swelling at injection site.  The patient sought unspecified medical attention.  The outcome of the patient was not reported.  Additional information has been requested.
Large swelling, erythema, tenderness of left arm and shoulder extending to elbow started a few hours after immunizations prior and lasted to some degree for a week
Moderna COVID?19 Vaccine EUA Dizziness at the time of injection that quickly went away. Dizziness returned about 1 hour and 50 minutes later and persisted for about 30 minutes. Difficulty standing and walking.  Still feeling "off" but not as dizzy at 12:22pm (almost 1 hour after onset of Dizziness).
Tested Covid positive.  Began with a bad sore throat and general feeling of unwell.  Spent 3 days solely in bed with severe headache, sore throat continued.  Slight fever although I never used a thermometer to verify.  The headache and sore throat continued for 2 full weeks with the sore throat staying at a very uncomfortable level.  The headache continued, with it lessening at times, but never going completely away.
fever; tachycardia; fatigue; headache; difficulty getting out of bed; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number 2G2T7, expiry date 15th November 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced fever, tachycardia, fatigue, headache and mobility decreased. In September 2019, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the tachycardia, fatigue, headache and mobility decreased were unknown.   It was unknown if the reporter considered the fever, tachycardia, fatigue, headache and mobility decreased to be related to Shingrix.  Additional case details were reported as follows: The patient experienced fever, which was resolved, and had tachycardia, fatigue, headache, difficulty getting out of bed. The reporter consented to follow up.
Developed what appears to be  a painful red bruise at the injection site about 10 days after shot. The spot appeared to darken and definitely progressively hurts more.
Suspected vaccination failure; developed shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter personally knew the patient, who received Shingles vaccine and developed shingles. The reporter stated that, it was not a vaccination if it did not prevent, it was only another money-making shot. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.    This was 1 of 7 linked cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR265680:Same reporter US-GLAXOSMITHKLINE-US2021AMR265681:Same reporter US-GLAXOSMITHKLINE-US2021AMR265682:Same reporter US-GLAXOSMITHKLINE-US2021AMR265683:Same reporter US-GLAXOSMITHKLINE-US2021AMR265649:Same reporter US-GLAXOSMITHKLINE-US2021AMR265685:Same reporter
11/06/02 site of DTaP immunization, very indurated, red and hot to touch. Diagnosis Cellulitis right upper arm, started swelling 11/6/02 AM. Rx erythromycin and kenalog ointment.
soreness in the left arm; This is a spontaneous report from a contactable consumer (patient). A 43-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number EN9581), via an unspecified route of administration, administered in left arm on 30Jan2021 at 15:00 (at the age of 43-year-old) as dose 1, single for COVID-19 immunization. Medical history and concomitant medications not reported. No other vaccine in four weeks and no other medication in two weeks of vaccination. The patient did not have covid prior vaccination. The patient not tested for covid post vaccination. On an unspecified date in 2021, after first vaccination, the patient experienced soreness in the left arm. The patient not received treatment for event. The outcome of events recovering at the time of report.  Follow-up attempts completed. No further information expected.
Second dose seemed to be placed higher than the first. Pain started roughly four hours later and I could not move my arm for 5 days at all without being in excruciating pain. I started stretching arm out and most of pain went away but I still cannot go to work and function normally without being in major pain, 9 days later.
3 days 1/18/13 post vaccine - pt awoke with pain & inability to bear weight (L) foot -> joint seen ED - 1/20/13 2 days later (R) foot with pain & difficulty bearing weight. ED visit - lower leg splint.
Initial report received on 14 December 2007 from the patient's parent. A 12-year old female, with no concurrent illnesses, pre-existing medical conditions, or use of other medications, had received a dose of Adacel (lot number "unknown") in the left deltoid on an "unknown" date. Minutes after receiving the vaccination, the patient became nauseated, saw spots and fainted to the floor. The patient spontaneously awoke within a minute; and the nurse stated the patient's blood pressure was low (blood pressure reading not reported). Blood pressure reading prior to the vaccination was not reported. No treatment for the adverse event was required. At the time of this report, the patient had recovered with "no sequelae."
PATIENT DID NOT SEEK MEDICAL TREATMENT, STATES RASH NEAR INJECTION SITE STARTED ABOUT A WEEK AFTER FIRST DOSE AND STILL PRESENT WHEN ARRIVED FOR SECOND DOSE, CLAIMS ITCHY AND IRRITATED.  USED OTC HYDROCORTISONE CREAM WHICH PROVIDED SOME RELIEF
Pt's mom gave  wrong DOB.  She presented with a DOB of 04-05-2005.  her actual DOB is 5-4-2005
pt recv vax 15MAR99 & 2 days later parent brought child into clinic lt arm swollen, tight, hot to touch from shoulder to hand nearly twice size of rt arms;
flu like reaction; Initial information was received on 07-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-health care professional via social media.  This case involves a female patient of unknown age who experienced flu like reaction (influenza like illness), while she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious flu like reaction (influenza like illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be information available on batch number for this case.
Moderate menstrual cramps; Back cramps; Early menstrual cycle; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 25-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol; levonorgestrel (SETLAKIN) for unspecified indication from an unknown date. On an unknown date, the patient experienced moderate menstrual cramps, back cramps and early menstrual cycle. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event moderate menstrual cramps, back cramps and early menstrual cycle was unknown at the time of report.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Joint stiffness to 3 fingers on right hand and Pluerisy to left chest with chest tightness, and  pain to left chest left scapula and left arm. I was examined by a medical doctor. I was given an X-ray and advised if symptoms persist after next week to return to the clinic
3 days post vax pt devel apthous ulcers on anterior tongue, lips & anterior buccal mucosa; posterior wall of pharynx swelled & pt lost her voice; pt was febrile; no temp was recorded; stomatitis;
A LUMP UNSPECIFIED IN THE AUXILIARY TAIL OF THE RIGHT BREAST (DISAPPEARED AROUND 2 WEEKS AND REAPPEARED ON 02-JUN-2021 WITH CHANGE IN THE SIZE); TIRED; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included pneumonia, and concurrent conditions included environmental allergies, asthma, and smoker. The patient experienced anaphylactic reaction (not confirmed) when treated with levofloxacin, and drug allergy ( dropped her blood pressure very low) when treated with morphine.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included epinephrine for asthma, omeprazole, and vitamin d.  On 06-APR-2021, the subject experienced tired. On 20-APR-2021, the subject experienced a lump unspecified in the auxiliary tail of the right breast (disappeared around 2 weeks and reappeared on 02-jun-2021 with change in the size). Laboratory data (dates unspecified) included: Mammogram (NR: not provided) lump in right breast, and Ultrasound breast (NR: not provided) Lump in right breast. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tired, and had not recovered from a lump unspecified in the auxiliary tail of the right breast (disappeared around 2 weeks and reappeared on 02-jun-2021 with change in the size). This report was non-serious.
Pt developed stiff neck, h/a & lt-sided Bell's Palsy; Rec'd 2nd dose on 23MAR90 experienced same sx;
Dizziness, imbalance, ear burning, ear pressure/plugging, head pressure, brain fog, brain zaps, head twitching, muscle twitching, heart palpitations, insomnia, nightmares and neck pain at first that subsided. I am still experiencing dizziness/imbalance feeling, on and off brain fog,  on and off ear pressure and insomnia.
No additional AE.; improperly stored vaccine was administered to a patient.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, concomitant medications and drug reactions/ allergies were not reported.  On 19-SEP-2022, the patient was vaccinated with an improperly stored (temperature: -11.8 Celsius [C] degrees, time frame: 1 hour, 45 minutes, 0 seconds) measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, lot #W019623 was found to be valid, expiration date: 19-DEC-2023 (strength, dose, route of administration and vaccination site were not reported) for prophylaxis (product storage error). No additional adverse events were reported.
This spontaneous report was received from the nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. The nurse stated that on 06-JAN-2015 the patient was vaccinated with a dose of expired PROQUAD (Merck), lot # J006162, expiry date: 30-NOV-2014 (site and route of administration were not reported). No adverse events were reported. Additional information has been requested.
Weakness and tenderness in legs, feeling loss, 7 day hospital treatment, medication, physical therapy still trying to recover now in 2015.
CDC reports: 22 mo developed pain, increased warmth, lump w/o abscess @ inject site & pain in joints following DTP/OPV/HIB immunization. Sx persisted for 2 days.
The patient was vaccinated with varicella on 02/24/1999 and developed chicken pox with several lesions on 10/16/2001.
Sudden onset shortness of breath from heart failure without other cause after in hospital admission and work up, patient stable after discharge.
First day tingling menthol feeling in mouth and jaw. Arm was sore. Mild headache, Shoulder pain, Mild pain arm. 12/17-12/18 arm pain got worse every day. 12/19 couldn't sleep at night. 12/20 limited motion in arm. Called doctor12/21. Took 400mg ibuprofen.  Took Medrol for shoulder pain. 12/22 not able to sleep. Dr. wrote rx for Flexerol.  Continued to take meds. Went back to work 12/23 with some pain.  By 12/26 much better.
Heart tachycardia out of rhythm. Given: Eliquis 2X/day; Multaq 400mg 2X/day; and Metropolol 1/2 tab (12.5mg) 2X/day